Home
About
Overview
Sharing Data
ORCID
Help
History (32)
Variation in caesarean and instrumental delivery rates in New Zealand hospitals.
Small molecule agonists of integrin CD11b/CD18 do not induce global conformational changes and are significantly better than activating antibodies in reducing vascular injury.
Improving access to specialist care for remote Aboriginal communities: evaluation of a specialist outreach service.
Tumor Necrosis Factor Receptor Superfamily, Member 7
Open-label support for duloxetine for the treatment of panic disorder.
See All 32 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Open-label support for duloxetine for the treatment of panic disorder.
Open-label support for duloxetine for the treatment of panic disorder. CNS Neurosci Ther. 2009; 15(1):19-23.
View in:
PubMed
subject areas
Adrenergic Uptake Inhibitors
Adult
Aged
Duloxetine Hydrochloride
Female
Humans
Male
Middle Aged
Panic Disorder
Thiophenes
authors with profiles
Mark Pollack